preview

Postherpetic Neuralgia Case Studies

Decent Essays

CC Fatigue. Headaches. Postherpetic neuralgia. S The patient is a 72-year-old female who tells me she continues on her Neurontin 300 mg one tablet b.i.d. At one point she tried to take more than this and got side effects. This does help with her postherpetic neuralgia. If she does miss a dose, she notices it. The patient has a history of migraines and has had continued ongoing issues with it. In the past, she had been on Imitrex injections, which were helpful, but she has not had these recently. She does take ibuprofen 200 mg one at a time, most two at a time. She does is perhaps three to four times per week. She stopped doing this recently however, because she read that ibuprofen can increase risk of coronary vascular disease. …show more content…

Pulse is 56. O2 saturation is 98% on room air. Weight is 123 pounds, which is down from 128 pounds in December 2014 and down from 134 pounds in May 2014. General The patient is alert, oriented, very pleasant, no acute distress. A/P Postherpetic neuralgia, symptoms improved with Neurontin. She will continue this. Migraine headaches, on Inderal long acting on a prophylactic basis. She had been taking ibuprofen, but was afraid to take it based on side effects that she read. I did suggest she could try Tylenol, but if this makes no difference at all that if she is only taking 200 to 400 mg three to four times per week and this does help her migraines, it is probably fairly low risk based on the benefit that she gets from it. Also suggested however, that if she has bad migraines, we may want to try sumatriptan once again. In the past, she was getting quite significant nausea and vomiting, but does not get these at this point. She is willing to try p.o. dose. I did give her Imitrex 50 mg one p.o. daily p.r.n., may repeat in two hours x1 dose of continuous headache. Healthcare maintenance. The patient had to cancel her physical in June because of a migraine. She was rescheduled for this sometime next year, but we will move that up to September, at this

Get Access